These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8981549)
21. Theoretical study on conformation-related activity of hypoglycemic sulfonylureas. Brasseur R; Deleers M Pharmacol Res Commun; 1983 Nov; 15(10):901-7. PubMed ID: 6336538 [TBL] [Abstract][Full Text] [Related]
22. Data on the combined action of insulin and hypoglycaemic sulphonylurea. TARDOS L; ERDELY I Acta Physiol Acad Sci Hung; 1961; 19():297-303. PubMed ID: 13775313 [No Abstract] [Full Text] [Related]
23. [Pharma-clinics. Medication of the month. Glimepiride (Amarylle)]. Scheen AJ Rev Med Liege; 2000 Mar; 55(3):184-6. PubMed ID: 10823010 [TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents. Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797 [TBL] [Abstract][Full Text] [Related]
26. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells. De Vries CP; van der Veen EA Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414 [TBL] [Abstract][Full Text] [Related]
27. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells. Best L; Benington S Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927 [TBL] [Abstract][Full Text] [Related]
28. PPARγ Agonistic Activity of Sulphonylureas. Banerjee D; Bharaj HS; Banerjee M Endocr Metab Immune Disord Drug Targets; 2019; 19(4):467-471. PubMed ID: 30605064 [TBL] [Abstract][Full Text] [Related]
29. [40 years of using sulfonylurea derivatives for treatment of diabetes]. Sieradzki J Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529 [TBL] [Abstract][Full Text] [Related]
31. [Clinically important effects of oral antidiabetic drug interactions]. Drzewoski J; Kopff B Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes. Müller G; Geisen K Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985 [TBL] [Abstract][Full Text] [Related]
33. Effects of gliquidone on D-glucose metabolism in rat pancreatic islets depend on hexose concentration. Picton S; Malaisse-Lagae F; Malaisse WJ Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):99-112. PubMed ID: 10100502 [TBL] [Abstract][Full Text] [Related]
34. Conformational analysis of the calcium complexes formed by meglitinide analogs. Lins L; Brasseur R; Malaisse WJ Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):153-64. PubMed ID: 8581340 [TBL] [Abstract][Full Text] [Related]
35. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492 [TBL] [Abstract][Full Text] [Related]
36. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Anwar A; Azmi KN; Hamidon BB; Khalid BA Med J Malaysia; 2006 Mar; 61(1):28-35. PubMed ID: 16708731 [TBL] [Abstract][Full Text] [Related]
37. Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. Yao J; Shi YQ; Li ZR; Jin SH J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):254-9. PubMed ID: 17409031 [TBL] [Abstract][Full Text] [Related]
38. Effect of glimepiride on the electrical activity of isolated rabbit heart muscle. Ballagi-Pordány G; Németh M; Aranyi Z; Kékesi E; Koltai MZ; Papp G; Pogátsa G Arzneimittelforschung; 1992 Feb; 42(2):111-3. PubMed ID: 1610416 [TBL] [Abstract][Full Text] [Related]
39. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels. Song DK; Ashcroft FM Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810 [TBL] [Abstract][Full Text] [Related]
40. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition. Fujitani S; Okazaki K; Yada T Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]